Income Statement (TTM)
Zealand Pharma A/S Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 301 | 192 | 347 | 161 | 158 | 109 | 114 | 104 | 93 | 104 | 107 | 92 | 343 | 343 | 344 | 368 | 77 | 63 | 56 | 9,110 |
| Change (%) | -36.31 | 80.52 | -53.60 | -1.45 | -31.50 | 4.84 | -8.64 | -10.07 | 11.22 | 2.57 | -14.05 | 274.67 | -0.20 | 0.43 | 6.89 | -79.11 | -18.45 | -11.16 | 16,256.96 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 62 | 91 | 74 | 39 | 11 | 11 | -0 | 0 | -12 | -9 | 3 | 8 | 30 | 19 | 8 | 4 | -5 | |||
| Change (%) | -18.76 | -46.67 | -72.04 | 0.00 | -100.64 | -100.00 | -30.14 | -137.29 | 143.88 | 279.16 | -34.92 | -59.05 | -53.24 | -246.58 | ||||||
| % of Revenue | 20.67 | 26.13 | 45.76 | 24.76 | 10.11 | 9.64 | -0.07 | 0.00 | -13.38 | -2.49 | 0.93 | 2.26 | 8.03 | 25.01 | 12.56 | 6.61 | -0.06 | |||
| Gross Operating Profit | 239 | 192 | 256 | 87 | 119 | 98 | 103 | 104 | 93 | 104 | 107 | 104 | 352 | 340 | 336 | 338 | 58 | 55 | 52 | 9,115 |
| Change (%) | -19.72 | 33.35 | -65.93 | 36.69 | -18.16 | 5.38 | 1.17 | -10.13 | 11.22 | 2.57 | -2.55 | 238.71 | -3.54 | -0.92 | 0.59 | -82.97 | -4.90 | -5.12 | 17,425.27 | |
| % of Revenue | 79.33 | 100.00 | 73.87 | 54.24 | 75.24 | 89.89 | 90.36 | 100.07 | 100.00 | 100.00 | 100.00 | 113.38 | 102.49 | 99.07 | 97.74 | 91.97 | 74.99 | 87.44 | 93.39 | 100.06 |
| SG&A | 300 | 222 | 575 | 480 | 416 | 298 | 231 | 286 | 273 | 258 | 241 | 215 | 205 | 216 | 244 | 270 | 314 | 404 | 431 | 461 |
| Change (%) | -25.92 | 158.43 | -16.42 | -13.46 | -28.26 | -22.43 | 23.67 | -4.61 | -5.36 | -6.82 | -10.55 | -4.86 | 5.44 | 13.10 | 10.40 | 16.36 | 28.78 | 6.79 | 6.87 | |
| % of Revenue | 99.58 | 115.83 | 165.82 | 298.70 | 262.32 | 274.73 | 203.27 | 275.16 | 291.87 | 248.37 | 225.62 | 234.79 | 59.62 | 62.99 | 70.94 | 73.27 | 408.13 | 644.47 | 774.69 | 5.06 |
| R&D | 612 | 596 | 574 | 595 | 595 | 582 | 602 | 606 | 612 | 614 | 601 | 605 | 656 | 685 | 734 | 790 | 856 | 920 | 1,019 | 1,272 |
| Change (%) | -2.59 | -3.58 | 3.53 | 0.02 | -2.25 | 3.52 | 0.68 | 1.02 | 0.29 | -2.16 | 0.70 | 8.47 | 4.37 | 7.11 | 7.63 | 8.44 | 7.44 | 10.80 | 24.79 | |
| % of Revenue | 202.91 | 310.34 | 165.75 | 369.86 | 375.39 | 535.73 | 529.01 | 582.96 | 654.90 | 590.51 | 563.26 | 659.90 | 191.05 | 199.80 | 213.09 | 214.56 | 1,113.74 | 1,467.30 | 1,830.09 | 13.96 |
| OpEx | 973 | 818 | 1,239 | 1,148 | 1,050 | 891 | 845 | 893 | 886 | 921 | 883 | 856 | 901 | 904 | 993 | 1,089 | 1,192 | 1,332 | 1,476 | 1,924 |
| Change (%) | -15.91 | 51.43 | -7.31 | -8.60 | -15.14 | -5.18 | 5.69 | -0.76 | 3.93 | -4.12 | -2.99 | 5.19 | 0.38 | 9.80 | 9.67 | 9.52 | 11.70 | 10.83 | 30.36 | |
| % of Revenue | 322.80 | 426.16 | 357.48 | 714.17 | 662.36 | 820.56 | 742.14 | 858.52 | 947.43 | 885.30 | 827.52 | 933.97 | 262.21 | 263.73 | 288.35 | 295.86 | 1,551.03 | 2,124.33 | 2,650.13 | 21.12 |
| Operating Income | -672 | -626 | -892 | -988 | -891 | -782 | -731 | -789 | -792 | -817 | -776 | -765 | -557 | -561 | -648 | -721 | -1,115 | -1,269 | -1,420 | 7,186 |
| Change (%) | -6.76 | 42.51 | 10.67 | -9.77 | -12.23 | -6.57 | 7.92 | 0.47 | 3.07 | -4.98 | -1.47 | -27.12 | 0.73 | 15.53 | 11.15 | 54.76 | 13.78 | 11.91 | -605.95 | |
| % of Revenue | -222.80 | -326.16 | -257.48 | -614.17 | -562.36 | -720.56 | -642.14 | -758.52 | -847.43 | -785.30 | -727.52 | -833.97 | -162.21 | -163.73 | -188.35 | -195.86 | -1,451.03 | -2,024.33 | -2,550.13 | 78.88 |
| Interest Expense | -22 | -49 | -4 | -3 | -3 | -4 | -20 | -27 | -34 | -58 | -50 | -53 | -44 | -26 | -21 | -21 | -29 | -34 | -35 | -32 |
| Change (%) | 120.62 | -92.06 | -18.93 | 5.96 | 21.68 | 393.28 | 31.78 | 29.60 | 67.67 | -13.21 | 5.31 | -17.11 | -41.01 | -19.36 | 2.91 | 34.87 | 17.77 | 4.25 | -9.71 | |
| % of Revenue | -7.41 | -25.68 | -1.13 | -1.97 | -2.12 | -3.77 | -17.73 | -25.58 | -36.87 | -55.58 | -47.03 | -57.62 | -12.75 | -7.54 | -6.05 | -5.83 | -37.61 | -54.31 | -63.73 | -0.35 |
| Net Income | -660 | -847 | -909 | -1,148 | -1,118 | -1,018 | -999 | -1,190 | -1,140 | -1,202 | -1,173 | -1,004 | -781 | -704 | -739 | -712 | -1,053 | -1,079 | -1,186 | 6,681 |
| Change (%) | 28.32 | 7.40 | 26.25 | -2.59 | -8.97 | -1.90 | 19.19 | -4.25 | 5.46 | -2.43 | -14.41 | -22.16 | -9.94 | 4.98 | -3.62 | 47.83 | 2.50 | 9.89 | -663.54 | |
| % of Revenue | -218.89 | -441.00 | -262.38 | -713.97 | -705.77 | -937.99 | -877.70 | -1,145.07 | -1,219.29 | -1,156.05 | -1,099.71 | -1,095.09 | -227.51 | -205.30 | -214.60 | -193.49 | -1,369.25 | -1,720.87 | -2,128.64 | 73.34 |
Source: Capital IQ
